We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Patient and family issues regarding genetic testing for cystic fibrosis: a review of prenatal carrier testing and newborn screening.
- Authors
Sparbel, Kathleen JH; Tluczek, Audrey
- Abstract
Cystic fibrosis (CF) is a potentially life-shortening autosomal recessive genetic condition resulting in chronic progressive respiratory involvement, malnutrition, electrolyte imbalance, and male infertility: It is the most common autosomal inherited condition in the White population, and its presence is recorded with varying prevalence across ethnicities, Since the 1989 discovery of the genetic variant F508del, the most common cystic fibrosis transmembrane conductance regulator (CFTR) mutation, more than 1,900 CF mutations have been identified, The 1997 National Institutes of Health (NIH) Consensus Statement on Cystic Fibrosis, along with 2001 and 2005 recommendations from the American College of Obstetricians and Gynecologists (ACOG), provide the basis for population CF carrier screening in the prenatal setting, Recommendations for newborn screening (NBS) for cystic fibrosis were released in 2004, with NBS programs in the United States initiated thereafter.
- Publication
Annual Review of Nursing Research, 2011, Vol 29, p303
- ISSN
0739-6686
- Publication type
Journal Article
- DOI
10.1891/0739-6686.29.303